Login / Signup

Improving the prescribing of palivizumab.

Simone TristEmily HorsleyHala KatfNatalie TaskerMona Mostaghim
Published in: Journal of paediatrics and child health (2018)
Palivizumab is often prescribed without meeting recognised best practice guidelines, and patients eligible are frequently not prescribed palivizumab. The streamlined IPU, implemented in hospital A, excluded patients who did not meet guidelines. The pro forma needs further refinement, and complementary strategies introduced to improve compliance.
Keyphrases
  • respiratory syncytial virus
  • primary care
  • healthcare
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • clinical practice
  • prognostic factors
  • adverse drug
  • quality improvement